SCHEMBL3169696

SCHEMBL3169696

CCCCc1ccc(NC(=O)N[C@@H](CCCNC(=N)N[N+](=O)[O-])C(=O)N[C@@H](CC(C)C)B2OC3CC4CC(C4(C)C)C3(C)O2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 19/20 0.50
PSMB11 A5LHX3 9/20 0.50
PSMA7 O14818 9/20 0.50
PSMB1 P20618 9/20 0.50
PSMA1 P25786 9/20 0.50
PSMA2 P25787 9/20 0.50
PSMA3 P25788 9/20 0.50
PSMA4 P25789 9/20 0.50
PSMB8 P28062 9/20 0.50
PSMB9 P28065 9/20 0.50
PSMA5 P28066 9/20 0.50
PSMB4 P28070 9/20 0.50
PSMB6 P28072 9/20 0.50
PSMB10 P40306 9/20 0.50
PSMB3 P49720 9/20 0.50
PSMB2 P49721 9/20 0.50
PSMA6 P60900 9/20 0.50
PSMA8 Q8TAA3 9/20 0.50
PSMB7 Q99436 9/20 0.50
PSMD11 O00231 8/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL607988 1.00 PSMB5 (0.50) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL15291259 0.92 PSMB5 (0.52) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL607634 0.92 PSEN1 (0.58) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL607519 0.92 PSMB5 (0.56) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL608848 0.91 PSMB5 (0.49) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL15628848 0.90 PSMB5 (0.53) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL12754423 0.89 PSMB5 (0.49) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL607673 0.89 PSEN1 (0.56) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL608417 0.88 PSMB5 (0.55) PSMB5PSMB11PSMA7PSMB1PSMA1
SCHEMBL12754424 0.88 PSMB5 (0.49) PSMB5PSMB11PSMA7PSMB1PSMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660507-B9 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON INC (US) 2010-03-24 EP disclosed
EP-1660507-B1 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON INC (US) 2009-08-05 EP disclosed